80 related articles for article (PubMed ID: 25200207)
41. Proline-directed protein kinase FA as a potential target for diagnosis and therapy of human cancers.
Yang SD
Curr Cancer Drug Targets; 2004 Nov; 4(7):591-6. PubMed ID: 15578916
[TBL] [Abstract][Full Text] [Related]
42. Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.
Liu B; Li C; Feng C; Wang H; Zhang H; Tu C; He S; Li Z
Front Immunol; 2023; 14():1178436. PubMed ID: 37377953
[TBL] [Abstract][Full Text] [Related]
43. The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology.
Astarita JL; Keerthivasan S; Husain B; Şenbabaoğlu Y; Verschueren E; Gierke S; Pham VC; Peterson SM; Chalouni C; Pierce AA; Lill JR; Gonzalez LC; Martinez-Martin N; Turley SJ
PLoS One; 2021; 16(12):e0260800. PubMed ID: 34879110
[TBL] [Abstract][Full Text] [Related]
44. FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1.
Kwon M; Rubio G; Nolan N; Auteri P; Volmar JA; Adem A; Javidian P; Zhou Z; Verzi MP; Pine SR; Libutti SK
Cancer Res; 2021 Nov; 81(21):5523-5539. PubMed ID: 34417201
[TBL] [Abstract][Full Text] [Related]
45. Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma.
Roth K; Coussement L; Knatko EV; Higgins M; Steyaert S; Proby CM; de Meyer T; Dinkova-Kostova AT
EBioMedicine; 2021 May; 67():103383. PubMed ID: 34000624
[TBL] [Abstract][Full Text] [Related]
46. In-Depth Characterization of Mass Spectrometry-Based Proteomic Profiles Revealed Novel Signature Proteins Associated with Liver Metastatic Colorectal Cancers.
Ku X; Xu Y; Cai C; Yang Y; Cui L; Yan W
Anal Cell Pathol (Amst); 2019; 2019():7653230. PubMed ID: 31781478
[TBL] [Abstract][Full Text] [Related]
47. The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis.
Dai C
Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1738):. PubMed ID: 29203710
[TBL] [Abstract][Full Text] [Related]
48. Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.
Reichert M
Exp Biol Med (Maywood); 2017 Jul; 242(13):1363-1375. PubMed ID: 28436273
[TBL] [Abstract][Full Text] [Related]
49. Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer.
Park YL; Park SY; Lee SH; Kim RB; Kim JK; Rew SY; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
Oncotarget; 2016 Nov; 7(44):72229-72241. PubMed ID: 27750216
[TBL] [Abstract][Full Text] [Related]
50. Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.
Kwon M; Lee SJ; Wang Y; Rybak Y; Luna A; Reddy S; Adem A; Beaty BT; Condeelis JS; Libutti SK
Int J Cancer; 2014 Jul; 135(1):48-60. PubMed ID: 24327474
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of Filamin A interacting protein 1-like Is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers [corrected].
Kwon M; Lee SJ; Reddy S; Rybak Y; Adem A; Libutti SK
PLoS One; 2013; 8(12):e82620. PubMed ID: 24340050
[TBL] [Abstract][Full Text] [Related]
52. Targeting the Wnt/β-catenin signaling pathway in human cancers.
Yao H; Ashihara E; Maekawa T
Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
[TBL] [Abstract][Full Text] [Related]
53. Wnt signaling and cancer development: therapeutic implication.
Paul S; Dey A
Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
[TBL] [Abstract][Full Text] [Related]
54. Filamin A interacting protein 1-like as a therapeutic target in cancer.
Kwon M; Libutti SK
Expert Opin Ther Targets; 2014 Dec; 18(12):1435-47. PubMed ID: 25200207
[TBL] [Abstract][Full Text] [Related]
55. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
